Proactive, a digital financial news organization, is hosting three intrepid companies on the fast track to growth at its latest North American virtual investor conference.
Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) (FRA:AGW), GreenBank Capital Inc (CSE:GBC) (OTCMKTS:GRNBF) and ProPhase Labs (NASDAQ:PRPH) will present at the virtual showcase event on February 16, 2021.
Hosted by Proactive’s Christine Corrado, the event kicks off at 1:00pm ET on Tuesday.
Algernon Pharmaceuticals is a drug repurposing company. In simple terms, this means it advances drugs that are safe and approved in one area but develops them for different indications/treatments.
So, the company may look again at a drug, which was tested for one disease, but may be better used for another. It focuses on treatments for billion-dollar global disease markets.
The firm believes repurposed compounds have a much lower risk of failing in human trials on safety issues. It says over 90% of drugs fail before Phase II, while development costs have ballooned to nearly US$2.5 billion, with an average timeline of 15 years.
Algernon Pharmaceuticals is led by CEO Christopher Moreau, a seasoned business professional in the life sciences sector with a strong background in biotechnology research, business development and a deep expertise in the capital markets. Moreau was previously CEO and Director of a publicly-traded company focused on the research & development of screening tests for prostate cancer, skin cholesterol and type 2 diabetes.
Commenting on the company’s plans for 2021, Algernon CEO Christopher Moreau said in a statement: “The company is in a unique position to leverage its capabilities in identifying compounds for repurposing and managing clinical trials, and to advance additional compounds into clinical studies in a timely and cost-effective manner.”
He added: “Our Chief Scientific Officer Dr. Mark Williams and I have stated many times that one of our key corporate goals was to have multiple compounds in clinical trials at the same time in order to improve our chances of a success, and that is what we intend to achieve.”
GreenBank Capital is a next-generation merchant banking business with a flexible low-cost overhead structure designed to help the business grow exponentially.
The company’s investment approach is to identify companies with the capacity for rapid growth with a strong management team that can be scaled and prepared for a public listing over a period of 6-24 months.
GreenBank’s portfolio companies comprise equity investments in 11 smallcap businesses, including: 19% of Staminier Limited, a United Kingdom Merchant Banking firm; 59.5% of Kabaddi Games Inc, developers of a mobile application game based on the sport of Kabaddi; 52.5% of Blockchain Evolution Inc, owners of the world’s first identification-based blockchain, and 21.4% of Ubique Minerals Limited, a zinc exploration company in Newfoundland.
The company reported recently that its portfolio company Staminier has exercised its option and has now completed the acquisition of P&H Motorcycles Ltd, the south of England’s biggest distributor of high-performance motorcycles, including Ducati, Yamaha, Kawasaki, Suzuki, KTM, Scrambler and Honda.
GreenBank Capital is led by David Lonsdale, President and CEO of US private equity company The Lonsdale Group. Previously, he was President of Allegiance Capital Corporation, a private investment bank focusing on mergers and acquisitions.
ProPhase Labs is a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements.
The company is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the US.
ProPhase Labs announced recently that it has begun new saliva-based, viral RT-PCR multiplex-testing as a laboratory-developed test classification. Emergency use authorization applications have been filed and confirmed by the US Food and Drug Administration (FDA) for its two new testing methodologies.
The company said its testing integrates the Spectrum Solutions saliva self-collection system with a new, advanced multiplex qPCR platform for the simultaneous RNA detection of not only COVID-19 but also its viral mutations, as well as Influenza A, B, and more.
ProPhase Labs is led by CEO Ted Karkus, who has long focused his career on investing, management consulting and managing emerging growth companies. Karkus previously financed and advised biotech/vaccine company ID Biomedical when it was valued at about $25 million. Seven years later, the company was sold to GlaxoSmithKline PLC (LON:GSK) for more than $1.4 billion.
About the event:
- Ours is an audience of astute high net worth investors, fund managers, private client brokers and analysts
- We look beyond the numbers and meet the people creating the value for shareholders
- Each company has a presentation slot followed by Q&A, giving you the chance to discover the real story
- You can watch the event afterwards on our YouTube channel
Story by ProactiveInvestors
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 888-809-8385 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
pathogens and gives you more
energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video)
Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.